HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

An ultra-low dose of naloxone added to lidocaine or lidocaine-fentanyl mixture prolongs axillary brachial plexus blockade.

AbstractINTRODUCTION:
In this prospective, randomized, double-blind study, we evaluated the effect of an ultra-low dose of naloxone added to lidocaine and fentanyl mixture on the onset and duration of axillary brachial plexus block.
METHODS:
One hundred twelve patients scheduled for elective forearm surgery under axillary brachial plexus block were randomly allocated to receive 34 mL lidocaine 1.5% with 3 mL of isotonic saline chloride (control group, n = 28), 34 mL lidocaine 1.5% with 2 mL (100 microg) of fentanyl and 1 mL of isotonic saline chloride (fentanyl group, n = 28), 34 mL lidocaine 1.5% with 2 mL saline chloride and 100 ng (1 mL) naloxone (naloxone group, n = 28), or 34 mL lidocaine 1.5% with 2 mL (100 microg) of fentanyl and 100 ng (1 mL) naloxone (naloxone + fentanyl group, n = 28). A multiple stimulation technique was used in all patients. After performing the block, sensory and motor blockades of radial, median, musculocutaneous, and ulnar nerves were recorded at 5, 15, and 30 min. The onset time of the sensory and motor blockades was defined as the time between the last injection and the total abolition of the pinprick response and complete paralysis, respectively. The duration of sensory and motor blocks was considered as the time interval between the complete block and the first postoperative pain and complete recovery of motor functions.
RESULTS:
Sensory and motor onset times were longer in the naloxone (sensory onset time: 15 +/- 3, and motor onset time: 21 +/- 4) and naloxone + fentanyl group than control or fentanyl groups (sensory onset time: 10 +/- 3 min in control group, 10 +/- 4 min in fentanyl group, and 17 +/- 3 min in naloxone + fentanyl group, motor onset time: 15 +/- 5 min in control group, 14 +/- 7 min in fentanyl group, and 17.3 +/- 3.4 min in naloxone + fentanyl group) (P < 0.001). The duration of time to first postoperative pain and motor blockade was significantly longer in the naloxone (92 +/- 10 and 115 +/- 10 min) and naloxone + fentanyl groups (98 +/- 12 and 122 +/- 16 min) than control (68 +/- 7 and 89 +/- 11 min) and fentanyl groups (68 +/- 11 and 90 +/- 12 min) (P < 0.001). The time to first postoperative pain was significantly longer in the naloxone and naloxone + fentanyl groups than in the control or fentanyl groups (P < 0.001).
CONCLUSIONS:
The addition of an ultra-low dose of naloxone to lidocaine 1.5% solution with or without fentanyl solution in axillary brachial plexus block prolongs the time to first postoperative pain and motor blockade but also lengthens the onset time.
AuthorsAli Movafegh, Behrang Nouralishahi, Mustafa Sadeghi, Omid Nabavian
JournalAnesthesia and analgesia (Anesth Analg) Vol. 109 Issue 5 Pg. 1679-83 (Nov 2009) ISSN: 1526-7598 [Electronic] United States
PMID19843808 (Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Analgesics, Opioid
  • Anesthetics, Local
  • Drug Combinations
  • Narcotic Antagonists
  • Naloxone
  • Lidocaine
  • Fentanyl
Topics
  • Adult
  • Analgesics, Opioid (administration & dosage, adverse effects)
  • Anesthetics, Local (administration & dosage, adverse effects)
  • Axilla (innervation)
  • Brachial Plexus
  • Double-Blind Method
  • Drug Combinations
  • Elective Surgical Procedures
  • Female
  • Fentanyl (administration & dosage, adverse effects)
  • Forearm (innervation, surgery)
  • Humans
  • Lidocaine (administration & dosage, adverse effects)
  • Male
  • Middle Aged
  • Naloxone (administration & dosage, adverse effects)
  • Narcotic Antagonists (administration & dosage, adverse effects)
  • Nerve Block (adverse effects, methods)
  • Pain Measurement
  • Pain Threshold (drug effects)
  • Pain, Postoperative (prevention & control)
  • Postoperative Nausea and Vomiting (chemically induced)
  • Prospective Studies
  • Pruritus (chemically induced)
  • Recovery of Function
  • Time Factors
  • Treatment Outcome
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: